BETA logo

Beta Drugs Limited Stock Price

NSEI:BETA Community·₹15.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

BETA Share Price Performance

₹0
-1818.50 (-100.00%)
₹0
-1818.50 (-100.00%)
Price ₹0

BETA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and overvalued.

1 Risk
0 Rewards

Beta Drugs Limited Key Details

₹3.8b

Revenue

₹1.7b

Cost of Revenue

₹2.1b

Gross Profit

₹1.7b

Other Expenses

₹414.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
41.09
55.52%
10.78%
60.4%
View Full Analysis

About BETA

Founded
1985
Employees
399
CEO
Rahul Batra
WebsiteView website
betadrugslimited.com

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.

Recent BETA News & Updates

Analysis Article May 22

Earnings Troubles May Signal Larger Issues for Beta Drugs (NSE:BETA) Shareholders

Investors were disappointed by Beta Drugs Limited's ( NSE:BETA ) latest earnings release. Our analysis has found some...

Recent updates

No updates